Yuichi Iwaki
2017
In 2017, Yuichi Iwaki earned a total compensation of $2.6M as President and Chief and Executive Officer at MediciNova, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $266,751 |
|---|---|
| Option Awards | $1,740,825 |
| Salary | $533,503 |
| Other | $16,200 |
| Total | $2,557,279 |
Iwaki received $1.7M in option awards, accounting for 68% of the total pay in 2017.
Iwaki also received $266.8K in non-equity incentive plan, $533.5K in salary and $16.2K in other compensation.
Rankings
In 2017, Yuichi Iwaki's compensation ranked 4,336th out of 14,666 executives tracked by ExecPay. In other words, Iwaki earned more than 70.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,336 out of 14,666 | 70th |
Division Manufacturing | 1,522 out of 5,768 | 74th |
Major group Chemicals And Allied Products | 440 out of 2,074 | 79th |
Industry group Drugs | 337 out of 1,730 | 81st |
Industry Pharmaceutical Preparations | 266 out of 1,329 | 80th |
Source: SEC filing on April 26, 2018.
Iwaki's colleagues
We found four more compensation records of executives who worked with Yuichi Iwaki at MediciNova in 2017.